Literature DB >> 12764151

Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.

George S Laszlo1, Neil M Nathanson.   

Abstract

Members of the interleukin-6 (IL-6) family of cytokines exert their biological effects via binding to their cognate ligand-binding receptor subunit on a target cell. The subsequent recruitment of the common signal transducer glycoprotein 130 and activation of the JAK/STAT and SHP-2/Ras/mitogen-activated protein kinase (MAPK) pathways are responsible for the majority of cellular responses elicited by IL-6 cytokines. Several types of experiments suggest that the Src family of kinases (SFK) also participates in IL-6 family cytokine-mediated signaling events. SYF cells, which lack expression of SFKs Src, Yes, and Fyn, were used to determine the role of SFKs in IL-6 family cytokine signaling and gene induction. SYF and wild type (WT) control fibroblasts displayed similar activation of signaling intermediates following stimulation with leukemia inhibitory factor (LIF). LIF-stimulated tyrosine phosphorylation of SHP-2 and subsequent activation of MAPK in SYF cells were identical to that seen in LIF-stimulated WT cells. Both LIF-stimulated tyrosine phosphorylation of STAT1 and STAT3, as well as LIF-stimulated DNA binding activity of STAT-containing nuclear complexes were indistinguishable when compared in SYF and WT cells. In addition, the phosphatidylinositol 3-kinase-sensitive Akt kinase and p38 MAPK were activated by LIF in both SYF and WT cells. Furthermore, LIF-stimulated expression of c-fos, egr-1, and suppressor of cytokine signaling-3 was retained in SYF cells. The IL-6 family cytokine oncostatin M was also capable of activating MAPK, STAT3, STAT1, Akt, and p38 in both WT and SYF cells. These results demonstrate that IL-6 family cytokines can activate a full repertoire of signaling pathways and induce gene expression independent of SFKs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764151     DOI: 10.1074/jbc.M303670200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells.

Authors:  Timothy M Piazza; Juu-Chin Lu; Kristopher C Carver; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2008-12-04

2.  Egr1 protein acts downstream of estrogen-leukemia inhibitory factor (LIF)-STAT3 pathway and plays a role during implantation through targeting Wnt4.

Authors:  Xiao-Huan Liang; Wen-Bo Deng; Ming Li; Zhen-Ao Zhao; Tong-Song Wang; Xu-Hui Feng; Yu-Jing Cao; En-Kui Duan; Zeng-Ming Yang
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

3.  Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy.

Authors:  Steven S Welc; Ivan Flores; Michelle Wehling-Henricks; Julian Ramos; Ying Wang; Carmen Bertoni; James G Tidball
Journal:  Nat Commun       Date:  2019-06-26       Impact factor: 17.694

4.  Cell signaling associated with Na(+)/K(+)-ATPase: activation of phosphatidylinositide 3-kinase IA/Akt by ouabain is independent of Src.

Authors:  Jian Wu; Evgeny E Akkuratov; Yan Bai; Cassie Miller Gaskill; Amir Askari; Lijun Liu
Journal:  Biochemistry       Date:  2013-11-23       Impact factor: 3.162

5.  High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.

Authors:  Hongwei Guo; Yabin Cheng; Magdalena Martinka; Kevin McElwee
Journal:  Oncotarget       Date:  2015-09-22

6.  Effect of leukocyte inhibitory factor on neuron differentiation from human induced pluripotent stem cell-derived neural precursor cells.

Authors:  Liping Xu; Jingyi Long; Chun Shi; Nianping Zhang; Ying Lv; Junda Feng; Aiguo Xuan; Xiaosong He; Qingqing Li; Yinshan Bai; Shanshan Liu; Dahong Long
Journal:  Int J Mol Med       Date:  2018-01-23       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.